Kinga Sałaciak

448 total citations
19 papers, 336 citations indexed

About

Kinga Sałaciak is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Kinga Sałaciak has authored 19 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Kinga Sałaciak's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Tryptophan and brain disorders (4 papers). Kinga Sałaciak is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Tryptophan and brain disorders (4 papers). Kinga Sałaciak collaborates with scholars based in Poland and United Kingdom. Kinga Sałaciak's co-authors include Karolina Pytka, Elżbieta Żmudzka, Jacek Sapa, Monika Głuch‐Lutwin, Bożena Muszyńska, Marcin Kołaczkowski, Katarzyna Sułkowska‐Ziaja, Joanna Śniecikowska, Adrian Newman‐Tancredi and Agata Siwek and has published in prestigious journals such as International Journal of Molecular Sciences, Neuroscience & Biobehavioral Reviews and Pharmacology & Therapeutics.

In The Last Decade

Kinga Sałaciak

19 papers receiving 333 citations

Peers

Kinga Sałaciak

CMN

PHARM

Elżbieta Żmudzka Poland

Kristína Holubová Czechia

Helene Fachim United Kingdom

Valentina Vozella United States

Melissa T. Manners United States

Ildikó Miklya Hungary

Lenka Kletečková Czechia

Karolina Podkowa Poland

Pelin Tanyerı Türkiye

M. Amin Khan United States

Elżbieta Żmudzka Poland

Kinga Sałaciak

165 ×1.1

CMN

155 ×1.1

116 ×1.4

93 ×1.2

PHARM

76 ×1.7

Citations per year, relative to Kinga Sałaciak Kinga Sałaciak (= 1×) peers Elżbieta Żmudzka

Countries citing papers authored by Kinga Sałaciak

Since Specialization

Citations

This map shows the geographic impact of Kinga Sałaciak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinga Sałaciak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinga Sałaciak more than expected).

Fields of papers citing papers by Kinga Sałaciak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kinga Sałaciak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinga Sałaciak. The network helps show where Kinga Sałaciak may publish in the future.

Co-authorship network of co-authors of Kinga Sałaciak

This figure shows the co-authorship network connecting the top 25 collaborators of Kinga Sałaciak. A scholar is included among the top collaborators of Kinga Sałaciak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinga Sałaciak. Kinga Sałaciak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sałaciak, Kinga, et al.. (2024). Beyond the blur: Scopolamine's utility and limits in modeling cognitive disorders across sexes – Narrative review. Ageing Research Reviews. 104. 102635–102635. 1 indexed citations

Żmudzka, Elżbieta, Kinga Sałaciak, Agata Siwek, et al.. (2023). Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice. Pharmaceuticals. 16(3). 399–399. 2 indexed citations

Sałaciak, Kinga, et al.. (2023). Memory impairments in rodent depression models: A link with depression theories. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 125. 110774–110774. 5 indexed citations

Głuch‐Lutwin, Monika, Kinga Sałaciak, Karolina Pytka, et al.. (2022). The 5-HT1A receptor biased agonist, NLX-204, shows rapid-acting antidepressant-like properties and neurochemical changes in two mouse models of depression. Behavioural Brain Research. 438. 114207–114207. 7 indexed citations

Sałaciak, Kinga, Magdalena Jastrzębska‐Więsek, Anna Partyka, et al.. (2022). HBK-15, a Multimodal Compound, Showed an Anxiolytic-Like Effect in Rats. Neurochemical Research. 48(3). 839–845. 1 indexed citations

Sałaciak, Kinga, Agata Siwek, Jacek Sapa, et al.. (2022). The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α1-Adrenolytic Properties. International Journal of Molecular Sciences. 23(18). 10381–10381. 2 indexed citations

Sałaciak, Kinga, Agata Siwek, Barbara Filipek, et al.. (2022). HBK-10, A Compound with α1-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats. Pharmaceuticals. 15(10). 1256–1256. 1 indexed citations

Głuch‐Lutwin, Monika, Kinga Sałaciak, Joanna Śniecikowska, et al.. (2021). The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress. Psychopharmacology. 238(8). 2249–2260. 15 indexed citations

Sałaciak, Kinga & Karolina Pytka. (2021). Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?. Pharmacology & Therapeutics. 227. 107872–107872. 33 indexed citations

10.

Sałaciak, Kinga & Karolina Pytka. (2021). Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders. Neuroscience & Biobehavioral Reviews. 132. 1114–1136. 46 indexed citations

11.

Sałaciak, Kinga, Natalia Malikowska‐Racia, Agata Siwek, et al.. (2021). Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors. Pharmaceuticals. 14(8). 744–744. 5 indexed citations

12.

Sałaciak, Kinga, et al.. (2021). The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia. Pharmaceuticals. 14(11). 1065–1065. 1 indexed citations

13.

Sałaciak, Kinga, et al.. (2021). The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders. International Journal of Molecular Sciences. 22(9). 4307–4307. 41 indexed citations

14.

Kotańska, Magdalena, et al.. (2020). Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model. Pharmacology Biochemistry and Behavior. 196. 172974–172974. 6 indexed citations

15.

Sałaciak, Kinga, Monika Głuch‐Lutwin, Agata Siwek, et al.. (2020). The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling. Journal of Psychopharmacology. 34(12). 1431–1442. 3 indexed citations

16.

Pytka, Karolina, Monika Głuch‐Lutwin, Elżbieta Żmudzka, et al.. (2018). HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling. Frontiers in Pharmacology. 9. 1146–1146. 15 indexed citations

17.

Żmudzka, Elżbieta, Kinga Sałaciak, Jacek Sapa, & Karolina Pytka. (2018). Serotonin receptors in depression and anxiety: Insights from animal studies. Life Sciences. 210. 106–124. 135 indexed citations

18.

Sułkowska‐Ziaja, Katarzyna, et al.. (2018). Laetiporus sulphureus – CHEMICAL COMPOSITION AND MEDICINAL VALUE. Acta Scientiarum Polonorum Hortorum Cultus. 17(1). 87–96. 15 indexed citations

19.

Sułkowska‐Ziaja, Katarzyna, et al.. (2016). Trametes versicolor (L.) Lloyd as a source of biologically active compounds with a wide spectrum of action and application. Postępy Fitoterapii. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact